Cargando…
Review: UK medicines likely to be affected by the proposed European Medicines Agency’s guidelines on phthalates
BACKGROUND: Phthalates are excipients in drug formulations. However, concerns have been raised about the effects of particular phthalates on reproduction and development. As a result the EMA has introduced guidelines for permitted daily exposure (PDE) limits for certain phthalates. Therefore, the ob...
Autores principales: | Jamieson, Lisa, McCully, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465162/ https://www.ncbi.nlm.nih.gov/pubmed/26070463 http://dx.doi.org/10.1186/s40360-015-0018-9 |
Ejemplares similares
-
Overview of the European Medicines Agency's Development of Product‐Specific Bioequivalence Guidelines
por: Sullivan, Jane O', et al.
Publicado: (2018) -
Dynamic Medicine: the start of a new online journal
por: Hamaoka, Takafumi, et al.
Publicado: (2002) -
European medicines agency guideline for biological medicinal products: a further step for a safe use of biosimilars
por: Agostini, Carlo, et al.
Publicado: (2015) -
Psychopharmacology at the era of EMEA (European Medicines Agency)
por: Pestana, Luis Camara, et al.
Publicado: (2010) -
A bacteriophage journey at the European Medicines Agency
por: Debarbieux, Laurent, et al.
Publicado: (2015)